Cytori Therapeutics Inc Stock Nasdaq
Equities
US23283K4022
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 5.07M | Sales 2025 * | 2.87M | Capitalization | 10.78M |
---|---|---|---|---|---|
Net income 2024 * | -15M | Net income 2025 * | -29M | EV / Sales 2024 * | 2.13 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.76 x |
P/E ratio 2024 * |
-0.91
x | P/E ratio 2025 * |
-0.82
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.82% |
Latest transcript on Cytori Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 62 | 02-09-30 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 20-02-05 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 62 | 02-09-30 |
Richard Hawkins
CHM | Chairman | 74 | 07-11-30 |
Robert Lenk
BRD | Director/Board Member | 76 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 47.96B | |
+44.70% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |